Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy
- 8 August 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 67 (3), 400-406
- https://doi.org/10.1212/01.wnl.0000232737.72555.06
Abstract
Objective: To compare the cognitive effects of lamotrigine vs topiramate as adjunctive therapy in adults with epilepsy. Methods: A multicenter, double-blind, randomized, prospective study was conducted in adults with partial seizures. Lamotrigine or topiramate was introduced as an adjunctive therapy to carbamazepine or phenytoin and titrated over 8 weeks to target doses. These drugs were maintained another 8 weeks (maintenance phase) without dosage changes. The primary endpoint was change from screening to the end of the maintenance phase in a combined analysis of standardized measures of cognition (Controlled Oral Word Association Task [COWA]; Stroop Color–Word Interference; Digit Cancellation; Lafayette Grooved Pegboard, dominant hand; Rey Auditory Verbal Learning Test, delayed recall; and Symbol–Digit Modalities test). Results: For the primary endpoint, cognitive performance at the end of the maintenance phase was better with lamotrigine than with topiramate (415.3 vs 315.1; p < 0.001). On the individual cognitive tests, performance was better with lamotrigine than with topiramate in mean changes from screening on the COWA (p < 0.001), Stroop Color–Word Interference (p = 0.038), and Symbol–Digit Modalities tests (p < 0.001). The treatment effect exceeded the minimum clinically important difference for the COWA and the Symbol–Digit Modalities test. Mean changes from screening in the Performance-On-Line test simulating driving skills reflected better performance with lamotrigine than with topiramate (p = 0.021). The median percentage change from baseline in seizure frequency was lower with lamotrigine than with topiramate during the escalation phase (−80% vs −100%; p = 0.028) but not during the maintenance phase (−75% vs −100%; p = 0.062). The frequencies of cognitive adverse events and of premature withdrawals related to cognitive decline were higher with topiramate than with lamotrigine (6% vs 0%; p = 0.013). Conclusion: Lamotrigine had significantly less impact than topiramate on measures of cognition when used as adjunctive therapy for partial seizures.Keywords
This publication has 28 references indexed in Scilit:
- Effect of Antiepileptic Drugs on Cognitive Function in Individuals with EpilepsyDrugs, 2002
- Postmarketing Experience with Topiramate and CognitionEpilepsia, 2001
- Effects of topiramate on cognitive functionJournal of Neurology, Neurosurgery & Psychiatry, 2000
- A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset SeizuresEpilepsia, 2000
- Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsyActa Neurologica Scandinavica, 2000
- Prediction of Driving Performance Through Computerized Testing: High-Risk-Driver Assessment and TrainingTransportation Research Record: Journal of the Transportation Research Board, 1999
- A PC‐Based Software Test for Measuring Alcohol and Drug Effects in Human SubjectsAlcohol: Clinical and Experimental Research, 1996
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Behavioral Characteristics of Epilepsy Patients Compared with Normal ControlsEpilepsia, 1986
- Differential clinical sensitivity of specific parameters of the Rey Auditory-Verbal Learning Test.Journal of Consulting and Clinical Psychology, 1983